Home › NDC Lookup › RxCUI directory › RxCUI 198182

Pyrimethamine 25 MG Oral Tablet — RxCUI 198182

RxNorm drug concept · Semantic clinical drug
RxCUI 198182 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198182
Official namePyrimethamine 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped7
Package NDCs mapped13
Reported Medicaid activity (SDUD)195 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Pyrimethamine 25 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pyrimethamine 25 MG Oral Tablet RxCUI 198182

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pyrimethamine 9010
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Daraprim 151583
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pyrimethamine Oral Tablet 373718
    • Pyrimethamine Oral Product 1164167
    • Pyrimethamine Pill 1164168
    • Pyrimethamine Oral Tablet [Daraprim] 369334
    • Daraprim Oral Product 1168167
    • Daraprim Pill 1168168
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pyrimethamine 25 MG SCDC · 316613
  • Pyrimethamine Oral Tablet SCDF · 373718
  • Pyrimethamine Oral Product SCDG · 1164167
  • Pyrimethamine Pill SCDG · 1164168

Brand-Name Concepts

  • Pyrimethamine 25 MG Oral Tablet [Daraprim] SBD · 201912
  • Pyrimethamine 25 MG [Daraprim] SBDC · 566054
  • Pyrimethamine Oral Tablet [Daraprim] SBDF · 369334
  • Daraprim Oral Product SBDG · 1168167
  • Daraprim Pill SBDG · 1168168
  • Daraprim BN · 151583

📦 FDA Products & Package NDCs

7 products · 13 package NDCs
13 package NDCs map to RxCUI 198182 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00480-3720-01 100 TABLET in 1 BOTTLE, PLASTIC (0480-3720-01) Pyrimethamine Teva Pharmaceuticals, Inc. 2021-12-15
00480-3720-56 30 TABLET in 1 BOTTLE, PLASTIC (0480-3720-56) Pyrimethamine Teva Pharmaceuticals, Inc. 2021-12-15
43598-0672-01 100 TABLET in 1 BOTTLE, PLASTIC (43598-672-01) Pyrimethamine DR.REDDYS LABORATORIES INC 2020-03-16
43598-0672-30 30 TABLET in 1 BOTTLE, PLASTIC (43598-672-30) Pyrimethamine DR.REDDYS LABORATORIES INC 2020-03-16
59651-0590-01 100 TABLET in 1 BOTTLE (59651-590-01) Pyrimethamine Aurobindo Pharma Limited 2022-10-25
59651-0590-30 30 TABLET in 1 BOTTLE (59651-590-30) Pyrimethamine Aurobindo Pharma Limited 2022-10-25
69413-0330-10 100 TABLET in 1 BOTTLE, PLASTIC (69413-330-10) Daraprim Vyera Pharmaceuticals LLC 1953-01-23
69413-0330-30 30 TABLET in 1 BOTTLE, PLASTIC (69413-330-30) Daraprim Vyera Pharmaceuticals LLC 1953-01-23
72603-0262-01 30 TABLET in 1 BOTTLE (72603-262-01) Pyrimethamine NorthStar Rx LLC 2024-10-01
72647-0330-01 100 TABLET in 1 BOTTLE, PLASTIC (72647-330-01) Pyrimethamine OAKRUM PHARMA, LLC 2020-03-13
72647-0330-03 30 TABLET in 1 BOTTLE, PLASTIC (72647-330-03) Pyrimethamine OAKRUM PHARMA, LLC 2020-03-13
83649-0330-01 100 TABLET in 1 BOTTLE, PLASTIC (83649-330-01) Daraprim TILDE Sciences LLC 2023-12-12
83649-0330-03 30 TABLET in 1 BOTTLE, PLASTIC (83649-330-03) Daraprim TILDE Sciences LLC 2023-12-12
Observed labelers: Aurobindo Pharma Limited (2) · DR.REDDYS LABORATORIES INC (2) · OAKRUM PHARMA, LLC (2) · Teva Pharmaceuticals, Inc. (2) · TILDE Sciences LLC (2) · Vyera Pharmaceuticals LLC (2) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$137.0090
Range $137.0090–$137.0090 · middle 50% $137.0090–$137.0090 · 6 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.